| Camera A, Rinaldi CR, Palmieri S, et al.
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome(R)) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. [JOURNAL ARTICLE]
Ann Hematol 2008 Aug 16.
Abstract | Full Citation | Find Related Articles |
| Mitchell PL, Marlton P, Grigg A, et al.
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma. [Journal Article]
Leuk Lymphoma 2008 May; 49(5):924-31.
Abstract | Full Citation | Find Related Articles |
| Jensen GM, Bunch TH
Conventional liposome performance and evaluation: lessons from the development of vescan. [Journal Article]
J Liposome Res 2007; 17(3):121-37.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Petre CE, Dittmer DP
Liposomal daunorubicin as treatment for Kaposi's sarcoma. [Journal Article]
Int J Nanomedicine 2007; 2(3):277-88.
Abstract | Full Citation | Find Related Articles |
| Löfgren C, Lehmann S, Jönsson-Videsäter K, et al.
Higher Plasma but not Intracellular Concentrations After Infusion With Liposomal Daunorubicin Compared With Conventional Daunorubicin in Adult Acute Myeloid Leukemia. [JOURNAL ARTICLE]
Ther Drug Monit 2007 Oct; 29(5):626-631.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| McTiernan A, Whelan J, Leahy M, et al.
A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma. [Journal Article]
Sarcoma 2006; 2006(1):41080.
Abstract | Full Citation |
| Lowis S, Lewis I, Elsworth A, et al.
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours. [JOURNAL ARTICLE]
Br J Cancer 2006 Aug 1.
Abstract | Full Citation |
| Candoni A, Michelutti A, Simeone E, et al.
Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins. [JOURNAL ARTICLE]
Eur J Haematol 2006 Jul 19.
Abstract | Full Citation | Find Related Articles |
| Szebeni J
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. [Journal Article, Review]
Toxicology 2005 Dec 15; 216(2-3):106-21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Fassas A, Anagnostopoulos A
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia. [Journal Article]
Leuk Lymphoma 2005 Jun; 46(6):795-802.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
